TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition December 11, 2023
Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B December 11, 2023
TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer December 5, 2023
Immunitas Therapeutics Announces Appointment of James Wooldridge as Chief Medical Officer and Upcoming Presentation at ASH 2023 Annual Meeting December 5, 2023
Longwood Healthcare Leaders San Francisco CEO to Convene Life Science Thought Leaders Prior to JPM December 4, 2023
TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years December 4, 2023
